TG Therapeutics Announces Scheduling Of Planned Oncologic Drug Advisory Committee Meeting
TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the U.S. Food and Drug Administration (FDA) has set a date of April 22, 2022 for the previously announced meeting of the Oncologic Drugs Advisory Committee (ODAC)